GAMCO Investors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

GAMCO Investors’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-64,211	Closed	-$2.17M	–	961
2021 Q2	$2.17M	Buy	+64,211	New	+$1.64M	0.02%	508

GAMCO Investors's CNST Position: Q3 2021 in Review

GAMCO Investors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 64,211 shares — an estimated $2.17M sold.

GAMCO Investors first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $2.17M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

GAMCO Investors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
GAMCO Investors sold 64,211 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.17M.
GAMCO Investors first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
GAMCO Investors's Constellation Pharmaceuticals, Inc. position peaked at $2.17M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on GAMCO Investors's 13F filing for Q3 2021, filed 12 Nov 2021.